Two-Stage Mitral Valve Anchor Assembly for Secure Percutaneous MR Reduction

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current percutaneous and minimally invasive mitral valve therapies face challenges in effectively reducing mitral regurgitation (MR) while preserving left ventricle geometry and avoiding complications such as stenosis, atrial fibrillation, and LV wall stress, with inadequate efficacy and high invasiveness being major issues.

Innovation Solution

A percutaneous mitral valve replacement system utilizing an anchoring structure with projections engaging the anatomical gutter of the mitral valve annulus, incorporating a tri-leaflet artificial valve and staged implantation to ensure secure anchoring, sealing, and minimal disruption of native valve function.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If surgical replacement or repair is performed, then mitral regurgitation is reduced, but invasiveness and risk are increased

Engineering Contradiction:
ImproveMR reduction efficacyVSAvoidinvasiveness and surgical risk
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent replaces the mechanical surgical approach with a percutaneous delivery system. The valve replacement device is delivered through a catheter inserted via the femoral artery, eliminating the need for open chest surgery, median sternotomy, and cardiopulmonary bypass. This substitution of delivery method directly reduces invasiveness and surgical risk while maintaining MR reduction efficacy.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent introduces a delivery catheter as an intermediary tool to transport the valve replacement device to the mitral valve location. This intermediary enables percutaneous access to the heart valve, allowing treatment without direct surgical exposure and reducing the harmful factors of surgical invasiveness.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Object-affected harmful factors

If percutaneous approach is used, then invasiveness is reduced, but anchoring reliability is worsened

Engineering Contradiction:
ImproveinvasivenessVSAvoidanchoring reliability
Core Design Contradiction:
Object-affected harmful factorsVSReliability

Solution Approach 1:

The anchoring system is segmented into multiple independent anchoring legs that can be deployed separately. Each leg can be advanced through the annulus and engaged with the ventricular wall independently, providing distributed anchoring force. This segmentation enables reliable anchoring through a percutaneous approach by spreading the anchoring function across multiple discrete elements rather than requiring a single complex anchoring mechanism.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent employs preliminary actions in the anchoring process: first the delivery catheter is positioned, then the anchoring legs are deployed and engaged with the ventricular wall before the valve replacement is completed. This staged preliminary anchoring ensures secure fixation is established prior to final valve installation, compensating for the limitations of percutaneous access.

Inventive Principle:
Principle #10Preliminary action

3Reliability

If valve replacement is performed, then MR is eliminated, but LV geometry and function may be compromised

Engineering Contradiction:
ImproveMR eliminationVSAvoidLV geometry alteration and wall stress
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent applies local quality by positioning the valve replacement device specifically at the mitral valve annulus rather than altering the entire ventricular structure. The anchoring legs are engaged locally with the ventricular wall at the annular level, providing support without requiring extensive modification of LV geometry. This localized approach eliminates MR while preserving overall ventricular function and geometry.

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The patent changes the parameter of valve replacement methodology from surgical to percutaneous, which inherently reduces the impact on LV geometry. The percutaneous approach allows for precise positioning and anchoring without the need for extensive surgical manipulation of the ventricular structure, thereby maintaining LV function and geometry while achieving MR elimination.

Inventive Principle:
Principle #35Parameter changes

4Reliability

If complex repair procedures are performed, then MR reduction is achieved, but procedure complexity and recurrence rate are increased

Engineering Contradiction:
ImproveMR reductionVSAvoidprocedure complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent extracts the complex surgical repair procedure and replaces it with a simplified percutaneous valve replacement system. By removing the need for complex surgical techniques and using a self-contained delivery and implantation system, the procedure complexity is reduced while maintaining effective MR reduction. The extracted complexity is contained within the device design rather than the procedural execution.

Inventive Principle:
Principle #2Taking out (Extraction)

Data Source

PatentUS20260069405A1Two stage anchor and mitral valve assembly
Publication Date: 2026.03.12 CAISSON INTERVENTIONAL LLC
  • US20260069405A1 patent drawing
  • US20260069405A1 patent drawing
  • US20260069405A1 patent drawing

AI summary

Systems and methods for medical interventional procedures, including approaches to valve implantation. In one aspect, the methods and systems involve a modular approach to mitral valve therapy.